• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IVX 16.7% 0.5¢

INVION LIMITED - News & Media

Invion Limited is an Australia-based life sciences company. The Company is engaged in the... Invion Limited is an Australia-based life sciences company. The Company is engaged in the research and development of Photosoft technology for the treatment of a range of cancers, atherosclerosis and infectious diseases. The Company is engaged in the clinical development of a PhotoDynamic Therapy (PDT) for cancer. Its photosensitizer (the agent used in PDT) is called IVX-PDT and is based on Photosoft Technology. Its PDT is an alternative to surgery, and in contrast to radiotherapy and chemotherapy, which are immunosuppressive, PDT causes acute inflammation, expression of heat-shock proteins, and invasion and infiltration of a tumor by leukocytes. It produces topical and intravenous products suitable for use in skin cancer and in solid tumors, such as those present in ovarian, prostate and lung cancer. It is developing a topical formulation of its photosensitizing agent, IVX-PDT, to treat superficial Basal Cell Carcinoma (sBCC), Actinic Keratosis (AK) and Squamous Cell Cancer (SCC).More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

No News & Media currently available.

(20min delay)
Last
0.5¢
Change
-0.001(16.7%)
Mkt cap ! $32.12M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $15.28K 3.056M

Buyers (Bids)

No. Vol. Price($)
4 880901 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 7143246 13
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
0.6¢
  Change
-0.001 ( 10.0 %)
Open High Low Volume
0.5¢ 0.6¢ 0.5¢ 971625
Last updated 14.46pm 03/05/2024 ?
IVX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.